Siolta Therapeutics Funding: $30M Raised, Series B (2020)
Siolta Therapeutics is a Biotech company based in San Francisco, CA. It has raised $30M in total funding. Latest round: Series B.
Siolta Therapeutics funding overview
Siolta Therapeutics is a Biotech company based in San Francisco, CA. Siolta Therapeutics has raised $30M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in September 2020. The round record for Siolta Therapeutics runs through 2020; nothing later has been disclosed. Investors on record include Khosla Ventures, Marc Benioff, Seventure, SymBiosis, Global Brain. 5 distinct backers are named across the disclosed rounds.
Siolta Therapeutics at a glance
Total raised
$30M
Latest round
Series B
Latest round date
September 2020
Industry
Biotech
Headquarters
San Francisco, CA
Notable investors
Khosla Ventures, Marc Benioff, Seventure, SymBiosis, Global Brain
Frequently asked about Siolta Therapeutics funding
How much has Siolta Therapeutics raised?
Siolta Therapeutics has raised $30M in total disclosed funding across the rounds on record.
Who has invested in Siolta Therapeutics?
Khosla Ventures, Marc Benioff, Seventure, SymBiosis, Global Brain are named among the investors backing Siolta Therapeutics.
What was the latest Siolta Therapeutics funding round?
The most recent disclosed round is a Series B, announced in September 2020.
Where is Siolta Therapeutics based?
Siolta Therapeutics is based in San Francisco, CA.
What sector does Siolta Therapeutics operate in?
Siolta Therapeutics is tracked under Biotech from San Francisco, CA, with $30M in disclosed funding.
When did Siolta Therapeutics last raise?
The last disclosed Siolta Therapeutics round closed in September 2020 at Series B.
Siolta Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in San Francisco below to benchmark round size and investor mix.
